WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, April 21, 2004, 24(16):4043-4051; doi:10.1523/JNEUROSCI.5343-03.2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (76)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gris, D.
Right arrow Articles by Weaver, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gris, D.
Right arrow Articles by Weaver, L. C.

 Previous Article  |  Next Article 

Neurobiology of Disease
Transient Blockade of the CD11d/CD18 Integrin Reduces Secondary Damage after Spinal Cord Injury, Improving Sensory, Autonomic, and Motor Function

Denis Gris,1,2 Daniel R. Marsh,1 Mark A. Oatway,1,2 Yuhua Chen,1 Eilis F. Hamilton,1 Gregory A. Dekaban,1,2,3 and Lynne C. Weaver1,2

1Spinal Cord Injury Team, BioTherapeutics Research Group, Robarts Research Institute, 2Graduate Program in Neuroscience, and 3Department of Microbiology and Immunology, University of Western Ontario, London, Ontario N6A 5K8, Canada

The early inflammatory response to spinal cord injury (SCI) causes significant secondary damage. Strategies that nonselectively suppress inflammation have not improved outcomes after SCI, perhaps because inflammation has both adverse and beneficial effects after SCI. We have shown that the selective, time-limited action of a monoclonal antibody (mAb) to the CD11d subunit of the CD11d/CD18 integrin, delivered intravenously during the first 48 hr after SCI in rats, markedly decreases the infiltration of neutrophils and delays the entry of hematogenous monocyte-macrophages into the injured cord. We hypothesized that this targeted strategy would lead to neuroprotection and improved neurological outcomes. In this study the development of chronic pain was detected in rats by assessing mechanical allodynia on the trunk and hindpaws 2 weeks to 3 months after a clinically relevant clip-compression SCI at the twelfth thoracic segment. The anti-CD11d mAb treatment reduced this pain by half. Motor performance also improved as rats were able to plantar-place their hindpaws and use them for weight support instead of sweeping movements only. Improved cardiovascular outcome was shown after SCI at the fourth thoracic segment by significant decreases in autonomic dysreflexia. Locomotor performance was also improved. These functional changes correlated with significantly greater amounts and increased organization of myelin and neurofilament near the lesion. The improved neurological recovery after the specific reduction of early inflammation after SCI demonstrates that this selective strategy increases tissue at the injury site and improves its functional capacity. This early neuroprotective treatment would be an ideal foundation for building later cell-based therapies.

Key words: spinal cord injury; integrin; inflammation; pain; autonomic; locomotor; myelin; neurofilament


Received Dec 3, 2003; revised March 12, 2004; accepted March 14, 2004.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
K. A. Kigerl, J. C. Gensel, D. P. Ankeny, J. K. Alexander, D. J. Donnelly, and P. G. Popovich
Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord
J. Neurosci., October 28, 2009; 29(43): 13435 - 13444.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
W. M. McKillop, J. W. Barrett, S. H. Pasternak, B. M. C. Chan, and G. A. Dekaban
The extracellular domain of CD11d regulates its cell surface expression
J. Leukoc. Biol., October 1, 2009; 86(4): 851 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. P. Stirling, S. Liu, P. Kubes, and V. W. Yong
Depletion of Ly6G/Gr-1 Leukocytes after Spinal Cord Injury in Mice Alters Wound Healing and Worsens Neurological Outcome
J. Neurosci., January 21, 2009; 29(3): 753 - 764.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Nakashima, S. A. Arnold, E. T. Mahoney, S. D. Sithu, Y. P. Zhang, S. E. D'Souza, C. B. Shields, and T. Hagg
Small-Molecule Protein Tyrosine Phosphatase Inhibition as a Neuroprotective Treatment after Spinal Cord Injury in Adult Rats
J. Neurosci., July 16, 2008; 28(29): 7293 - 7303.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. R. Byrnes, B. A. Stoica, S. Fricke, S. Di Giovanni, and A. I. Faden
Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury
Brain, November 1, 2007; 130(11): 2977 - 2992.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. C. Bullard, X. Hu, J. E. Adams, T. R. Schoeb, and S. R. Barnum
p150/95 (CD11c/CD18) Expression Is Required for the Development of Experimental Autoimmune Encephalomyelitis
Am. J. Pathol., June 1, 2007; 170(6): 2001 - 2008.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. C. Fleming, M. D. Norenberg, D. A. Ramsay, G. A. Dekaban, A. E. Marcillo, A. D. Saenz, M. Pasquale-Styles, W. D. Dietrich, and L. C. Weaver
The cellular inflammatory response in human spinal cords after injury
Brain, December 1, 2006; 129(12): 3249 - 3269.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. Bouhy, B. Malgrange, S. Multon, A.-L. Poirrier, F. Scholtes, J. Schoenen, and R. Franzen
Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages
FASEB J, June 1, 2006; 20(8): 1239 - 1241.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. A. Oatway, Y. Chen, J. C. Bruce, G. A. Dekaban, and L. C. Weaver
Anti-CD11d Integrin Antibody Treatment Restores Normal Serotonergic Projections to the Dorsal, Intermediate, and Ventral Horns of the Injured Spinal Cord
J. Neurosci., January 19, 2005; 25(3): 637 - 647.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-